U.S. drug development Phase success rates, by drug classification 2011-2020
This statistic shows the probability of success for new drugs in the U.S. through the various stages of development, from January 1, 2011, to November 30, 2020, by drug classification. It was found that the probability of success from phase I to phase II was quite similar for NMEs, biologics, and vaccines